Global Gene Editing Market Size & Trends Report Segmented by Technology (CRISPR, TALENs, ZFN, Others), Product & Service (Reagents & Consumables, Software, Services), Application (Genetic Engineering, Clinical Applications), End User & Regional Forecasts to 2029
The gene editing market is experiencing robust growth, with a projected CAGR of around 16-18% over the coming years. This expansion is driven by advancements in gene-editing tools, growing investment in research and development, and an increasing number of applications in therapeutic and agricultural fields. The market’s trajectory reflects rising interest from biotech and pharmaceutical companies aiming to leverage gene editing for innovative treatments and crop enhancements. To learn more about the research report, download a sample report.
Report Overview
The gene editing market involves developing, selling, and applying technologies that allow for precise alterations in the DNA sequence of an organism's genome. Key techniques in this market, like CRISPR-Cas9, TALENs, and zinc finger nucleases, transform various sectors by allowing targeted genetic changes with remarkable precision. In healthcare, gene editing holds enormous potential for treating genetic diseases at their source by correcting the mutations responsible for conditions such as cystic fibrosis, muscular dystrophy, and certain cancers. This approach can offer patients lasting or even permanent relief by directly addressing the root cause of the disease. In agriculture, gene-editing technologies enhance crop resilience, improve yield, and increase nutritional value, supporting global food security initiatives.
To learn more about this report, download the PDF brochure
Rising Burden of Genetic Disorders Propels Gene Editing Market
The increasing global prevalence of genetic disorders is significantly amplifying the demand for gene-editing technologies. Conditions like cystic fibrosis, muscular dystrophy, and sickle cell anaemia, which stem from specific genetic mutations, affect millions worldwide and often lack effective, lasting treatments. Gene editing offers an innovative approach by targeting and correcting the underlying genetic errors, making it possible to provide curative rather than symptomatic therapies. This ability to directly address genetic causes positions technologies like CRISPR as highly sought-after solutions, offering new hope to patients and driving substantial growth in the market as healthcare stakeholders embrace the potential for personalized, gene-targeted treatments.
CRISPR Advancements Paving the Way for Clinical Applications
The rapid advancement of CRISPR technology is shaping the future of gene editing, transforming it from a research tool into a viable therapeutic option. Innovations in CRISPR’s precision and the development of innovative delivery mechanisms have reduced off-target effects, making the technology safer and more reliable for human therapeutic use. As a result, CRISPR-based therapies have moved from concept to reality, with clinical trials underway for various conditions including genetic disorders, certain cancers, and viral infections. This progression reflects not only the technological strides in CRISPR but also the increasing feasibility of in vivo editing, where gene modifications can be made directly within a patient’s body. The expansion of CRISPR applications into clinical settings is expected to further boost market growth, as it opens new avenues for treating previously untreatable conditions and paves the way for broader acceptance of gene-editing solutions in medicine.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global gene editing market features both established and emerging players, including Merck KGaA; Cibus Inc.; Recombinetics; Sangamo Therapeutics; Editas Medicine; Precision BioSciences; CRISPR Therapeutics; Intellia Therapeutics Inc.; Caribou Biosciences, Inc; Cellectis S.A.; and AstraZeneca, among others. Leading companies are focusing on strategies such as product innovation and development, forging strategic partnerships and collaborations, and expanding their geographic footprint to enhance their market positions.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2023 |
| Historical Data | 2022 - 2023 |
| Forecast Period | 2024 - 2029 |
| Growth Rate | CAGR of 16-18% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Technology, Product & Service, Application and End User |
| Regional Scope |
|
| Key Companies Mapped | Merck KGaA; Cibus Inc.; Recombinetics; Sangamo Therapeutics; Editas Medicine; Precision BioSciences; CRISPR Therapeutics; Intellia Therapeutics Inc.; Caribou Biosciences, Inc; Cellectis S.A.; and AstraZeneca among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides size of the gene editing market at the regional- and country-level from 2022 to 2029. The report further segments the market on the basis of technology, product & service, application and end user.
- Market Size & Forecast (2022-2029), By Technology, USD Million
- CRISPR
- TALENs
- ZFN
- Antisense
- Others
- Market Size & Forecast (2022-2029), By Product & Service, USD Million
- Reagents & Consumables
- Software
- Services
- Market Size & Forecast (2022-2029), By Application, USD Million
- Genetic Engineering
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Others
- Clinical Applications
- Diagnostics
- Therapy Development
- Genetic Engineering
- Market Size & Forecast (2022-2029), By End User, USD Million
- Biotechnology and Pharmaceutical Companies
- Academic & Research Institutes
- Others
- Market Size & Forecast (2022-2029), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
-
What is the market size & forecast of the gene editing market?
-
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the gene editing market?
-
What are the key trends defining the market?
-
What are the major factors impacting the market?
-
What are the opportunities prevailing in the market?
-
Which region has the highest share in the global market?
-
Which region is expected to witness the highest growth rate in the next 5 years?
-
Who are the major players operating in the market?
-
What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Gene Editing Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of genetic disorders
- Advancements in gene-editing technologies
- Expanding applications in therapeutics and personalized medicine
- Growing demand for gene-modified crops
- Increased funding for genomics and biotech research
- Restraints
- Ethical concerns surrounding genetic manipulation
- High costs associated with gene-editing tools
- Regulatory and safety concerns regarding clinical applications
- Opportunities
- Expansion of gene-editing applications for chronic and rare disease treatment
- Potential for gene editing in agricultural biotech to improve crop resilience
- Key Market Trends
- Increasing focus on in vivo gene-editing advancements
- Progression of CRISPR-based therapies in clinical trials
- Unmet Market Needs
- Industry Speaks
- Regulatory Analysis
- Drivers
- Market Dynamics
- Global Gene Editing Market Size & Forecast (2022-2029), By Technology, USD Million
- Introduction
- CRISPR
- TALENs
- ZFN
- Antisense
- Others
- Global Gene Editing Market Size & Forecast (2022-2029), By Product and Service, USD Million
- Introduction
- Reagents & Consumables
- Software
- Services
- Global Gene Editing Market Size & Forecast (2022-2029), By Application, USD Million
- Introduction
- Genetic Engineering
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Others
- Clinical Applications
- Diagnostics
- Therapy Development
- Global Gene Editing Market Size & Forecast (2022-2029), By End User, USD Million
- Introduction
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Others
- Global Gene Editing Market Size & Forecast (2022-2029), By Region, USD Million
- Introduction
- North America Gene Editing Market Size & Forecast (2022-2029), By Country, USD Million
- US
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Gene Editing Market Size & Forecast (2022-2029), By Country, USD Million
- UK
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- North America Gene Editing Market Size & Forecast (2022-2029), By Country, USD Million
- Introduction
-
-
- Asia Pacific (APAC) Gene Editing Market Size & Forecast (2022-2029), By Country, USD Million
- China
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Gene Editing Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Gene Editing Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Asia Pacific (APAC) Gene Editing Market Size & Forecast (2022-2029), By Country, USD Million
-
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Merck KGaA
- Cibus Inc.
- Recombinetics
- Sangamo Therapeutics
- Editas Medicine
- Precision BioSciences
- CRISPR Therapeutics
- Intellia Therapeutics Inc.
- Caribou Biosciences, Inc
- Cellectis S.A.
- AstraZeneca
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Biotechnology and Pharmaceutical Companies, Academic & Research Institutes and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
